bionity.com

Berlin, Germany Founded: 2000 • Age: 26 yrs
Information on life sciences, biotechnology, and pharma is offered online.

About bionity.com

bionity.com is a company based in Berlin (Germany) founded in 2000. It operates as a Advertising Model and Aggregator Model. bionity.com has completed 1 acquisition, including StemSource. bionity.com offers products and services including Industry Portal and Newsletter Service.

  • Headquarter Berlin, Germany
  • Sectors
    Media & Entertainment
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bionity.com/de
  • Social LinkedIn X
  • Legal Name Lumitos Ag
Key Metrics

Products & Services of bionity.com

bionity.com offers a comprehensive portfolio of products and services, including Industry Portal and Newsletter Service.

Industry Portal
Digital Platform

A platform for biotechnology and life sciences information.

Newsletter Service
Information Service

Regular updates on biotech and pharma industry news.

Funding Insights of bionity.com

  • Total Rounds 7
  • Last Round Grant β€” $532,637
  • First Round $73,906

    (Feb 2015)

  • Investors Count 1

All 7 funding rounds of bionity.com with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2020$532,637Grant––
Oct 2019$575,672Grant––
Apr 2017$264,147Grant––
Mar 2017$106,897Grant––
Apr 2015$269,210Grant––
Mar 2015$496,814Grant––
Feb 2015$73,906Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in bionity.com

bionity.com has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for bionity.com

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of bionity.com

1 people are tracked at bionity.com (1 in leadership).

NameRoleGroup
Christian Fischer
CEOLeadership
Premium access

Complete people profiles for bionity.com

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by bionity.com

bionity.com has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include StemSource.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Adipose-derived stem cells are banked for regenerative therapies.
stemsource.comThousand Oaks, United States2000Oct 2002β€’β€’β€’β€’
Premium access

Complete acquisition details for bionity.com

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of bionity.com

4 dated milestones of bionity.com across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded bionity.com is founded.
  2. Acquisition Acquires StemSource.
  3. Funding First funding round of $74K.
  4. Funding Latest funding round, Grant, of $533K.

Web traffic of bionity.com

The website of bionity.com (bionity.com) receives about 186.2K visits a month.

  • Monthly visits
    186.2K

    ▲ 21.5% vs previous month

Similar websites

Websites whose visitors overlap most with bionity.com. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
vbio.de
vbio.de
100%
–#2,486,227–
biospace.com
84%
720.1K#88,394View details
chemie.de
chemie.de
73%
–#183,927–
chemeurope.com
73%
193.6K#248,290View details
europeanpharmaceuticalreview.com
europeanpharmaceuticalreview.com
72%
–#527,236–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for bionity.com

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to bionity.com

10 companies that operate in the same segment as bionity.com (Materials & Industry Media), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Media publishing services are provided for business sectors.
1916Detroit, Michigan, United States–––
Operates a content website focused on the entertainment industry.
2004Chennai, Tamil Nadu, India–USD 469.03 K18
News and insights for the home furnishings industry are provided.
2018United States–––
Investment-focused online magazines for mining are published.
1908Sydney, New South Wales, Australia–––
Bio-based agricultural inputs are manufactured for sustainable farming.
1999Ramsey, Minnesota, United States–––
Media services focused on printing industry news, events, and analysis.
2008Mumbai, Maharashtra, India–USD 262.65 K1
Industry news and insights on pharmaceuticals are provided by pharmaphorum.
2009West Byfleet, United Kingdom–––
A B2B magazine covering manufacturing news, insights, and technology.
2014Mumbai, Maharashtra, India–––
A mobile-first professional network focused on the fashion industry.
2014Mumbai, Maharashtra, India–––
Cargo and logistics publication focused on industry news and services in India.
2012Delhi, Delhi, India–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about bionity.com

bionity.com was founded in 2000 and raised its 1st funding round 15 years after it was founded.

bionity.com is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Christian Fischer is the current CEO of bionity.com.

A digital platform focused on biotechnology, pharma, and life sciences is provided by bionity.com. Industry news, supplier directories, product information, and job listings are aggregated for professionals in research, industry, and science. Various sectors including diagnostics, laboratory analytics, and production technology are covered. Solutions for B2B marketing and visibility are offered to companies within these fields.

bionity.com offers Industry Portal and Newsletter Service.

bionity.com has made 1 acquisition, including StemSource.

bionity.com has 1 investor. Key investors include European Union.

bionity.com operates through Lumitos Ag.

The website of bionity.com receives about 186 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available